In a 2023 meta-analysis of adults with age-related cognitive decline, choline alphoscerate was associated with measurable improvement in cognitive test scores — the signal was strongest in older and impaired adults and thinner in healthy young people.
Directional pooled effect; strongest in older/impaired adults.









